Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
World Neurosurgery
|
September 11, 2019
The Thriving Neurosurgeon
Wayne M Sotile, Gary R Simonds
Clinical Obstetrics and Gynecology
|
July 26, 2019
Moving From Physician Burnout to Resilience
Wayne M Sotile, Rebecca S Fallon, Gary R Simonds
Cureus
|
November 14, 2019
The Effects of 24-Hour Neurosurgical Call on Fine Motor Dexterity, Cognition, and Mood
Cara M Rogers, Brian Saway, Christopher M Busch, et al.
Cureus
|
January 17, 2019
Economic Impact of Hospitalization Past Maximal Neurosurgical Inpatient Benefit
Cara M Rogers, Christopher M Busch, Joshua A Cuoco, et al.
Oncotarget
|
November 19, 2016
Patient-derived glioblastoma stem cells respond differentially to targeted therapies
Pratik Kanabur, Sujuan Guo, Gary R Simonds, et al.
Neuro-Oncology
|
October 11, 2017
PIK3CB/p110β is a selective survival factor for glioblastoma
Kevin J Pridham, Lamvy Le, Sujuan Guo, et al.
Cancer Research
|
November 7, 2015
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide
Susan F Murphy, Robin T Varghese, Samy Lamouille, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
World Neurosurgery
|
September 11, 2019
The Thriving Neurosurgeon
Wayne M Sotile, Gary R Simonds
Clinical Obstetrics and Gynecology
|
July 26, 2019
Moving From Physician Burnout to Resilience
Wayne M Sotile, Rebecca S Fallon, Gary R Simonds
Cureus
|
November 14, 2019
The Effects of 24-Hour Neurosurgical Call on Fine Motor Dexterity, Cognition, and Mood
Cara M Rogers, Brian Saway, Christopher M Busch, et al.
Cureus
|
January 17, 2019
Economic Impact of Hospitalization Past Maximal Neurosurgical Inpatient Benefit
Cara M Rogers, Christopher M Busch, Joshua A Cuoco, et al.
Oncotarget
|
November 19, 2016
Patient-derived glioblastoma stem cells respond differentially to targeted therapies
Pratik Kanabur, Sujuan Guo, Gary R Simonds, et al.
Neuro-Oncology
|
October 11, 2017
PIK3CB/p110β is a selective survival factor for glioblastoma
Kevin J Pridham, Lamvy Le, Sujuan Guo, et al.
Cancer Research
|
November 7, 2015
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide
Susan F Murphy, Robin T Varghese, Samy Lamouille, et al.
Page
of 1